The Leukemia & Lymphoma Society's (LLS's) academic grants support and encourage basic and translational leukemia, lymphoma and myeloma research.
LLS investigators are outstanding scientists at the forefront of leukemia, lymphoma and myeloma research at centers throughout the world. We award academic grants for studies that range from basic blood cancer research to research that uses the latest tools of genomics.
And we don't stop there. We're also dedicated to funding blood cancer research to help improve the quality of life for patients and their families with our projects studying long-term and late effects.
Visit LLS's Research Portal to apply for funding from LLS.
Learn more
A resource for those with currently active LLS grants or awards.
Learn more
Highlighting brand new publications and advances produced by LLS-funded blood cancer research.
View
See a list of the investigators whose projects were awarded funding in 2018. 2019 list coming soon!
View List
The Leukemia & Lymphoma Society (LLS), the Mark Foundation for Cancer Research (MFCR), and The Paul G. Allen Frontiers Group (PAFG) are proud to announce the Blood Cancer Discoveries Grant Program (BCDG), a new grant program designed to encourage basic research, technological innovation, and informatics pipeline development that can lead to an understanding of blood cancer disease mechanisms, the development...
The Leukemia & Lymphoma Society (LLS) offers career development awards to postdoctoral fellows and instructors, as well as early-career independent investigators, engaging in basic, clinical, or translational research to help understand and treat hematologic malignancies and relevant premalignant condicitons. Please verify in our Guidelines & Instructions which award is appropriate for your level of experienc...
The Translational Research Program (TRP) puts you on the bench-to-bedside fast track when it comes to finding better treatment and cures for leukemia, lymphoma and myeloma. The Leukemia & Lymphoma Society funds new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application. The 2019-2020 Translational Research Program RFP is now ...
LLS’s Specialized Center of Research (SCOR) grant program is intended to bring together established investigators from one or several institutions to develop a focused research program, foster new interactions and cooperation, and enhance interdisciplinary research among the participants. The overall goal of this mechanism is to enhance the development of innovative strategies for the treatment, diagnosis or p...
The Leukemia & Lymphoma Society is opening a new program, Impactful Medicine Providing Access to Clinical Trials ("IMPACT"), intended to expand access to high-quality clinical trials to patients served by community health settings, particularly rural, minority, and/or economically disadvantaged blood cancer patients. As many more clinical trials now use precision medicine, based in part on mutation...
The Screen to Lead Program will not open for new applications in the 2019-2020 application cycle. The Leukemia & Lymphoma Society (LLS) is sponsoring and issuing this Request for Applications (RFA) from qualified academic laboratories for drug discovery support specifically directed towards medicinal chemistry and/or drug target screening in hematological malignancies. LLS recognizes a significan...
The RTFCCR/LLS Patient-Focused Prevention is not currently open for new applications. The Rising Tide Foundation for Clinical Cancer Research and the Leukemia & Lymphoma Society partner in an international competitive grant to advance breakthroughs in prevention for blood cancers. The grant is focused on addressing four critical topics and is endowed with a total of USD $3 million. ...
The Mantle Cell Lymphoma Research Initiative is not currently open for new applications. The Leukemia & Lymphoma Society (LLS) announces a competitive grant program to benefit mantle cell lymphoma (MCL) patients. This is a milestone-driven research program with an overarching goal to move discoveries quickly from the bench to the clinic. The program is intended to bring together at least 3 ind...
RTFCCR/LLS Patient-Focused Immunotherapy Research Grant for Blood Cancer is not currently open for new applications. The Rising Tide Foundation for Clinical Cancer Research (RTFCCR), a private foundation in Switzerland, is focused on funding promising, innovative translational studies and clinical trials that hold the promise of delivering hopeful, encouraging and immediate options for cancer patients ...
The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) and The Leukemia & Lymphoma Society (LLS) are proud to announce the third IWMF-LLS STRATEGIC RESEARCH ROADMAP INITIATIVE: A Request for Proposals (RFP) to help further knowledge in four key domains of Waldenstrom’s macroglobulinemia (WM) research:
The Leukemia & Lymphoma Society (LLS) is partnered with the MPN Research Foundation (MPNRF) to support a grant program whose objective is to change the trajectory and ultimate prognosis for patients with myeloproliferative neoplasms, particularly myelofibrosis, polycythemia vera and essential thrombocythemia. The MPN Challenge program represents an important partnership between LLS and MPNRF, who share a mi...